The Effect of Sarcopenia on Postoperative Complications after Curative Pancreatectomy for Adenocarcinoma

Effect of Sarcopenia on Postoperative Complications

  • ümit mercan Surgical Oncology, General Surgery Department, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • ogün erşen Surgical Oncology, General Surgery Department, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Ali Ekrem Ünal Surgical Oncology, General Surgery Department, Faculty of Medicine, Ankara University, Ankara, Turkey.

Abstract

Objective: This study aimed to investigate the effect of sarcopenia on the development of serious postoperative complications in patients who underwent curative pancreatectomy for pancreatic cancer.
Methods: Total psoas index (TPI) was calculated for sarcopenia diagnosis by measures of psoas muscle area on the level of L3 spine from preoperative staging computerised tomograhpy (CT) images in pancreatic cancer patients undergoing curative resection. Patient demographics and postoperative outcomes were analised  in sarcopenic and non-sarcopenic group.
Results: It has been found to be statistically significant relation between severe postoperative complication and sarcopenia (p=0,001>). Sarcopenia was more associated with cardiac and pulmoner complications among others (p=0.007, p=0.003 respectively). In multivariate analysis, age (OR: 1,08. %95 CI: 1,01~1,15, p=0,013), ASA score (OR: 2,84. 95% CI 1,62 ~ 4,97. p= 0,043) and TPI (OR: 3,61. 95% CI: 1,58 ~ 5,74. p= 0,001>) has been found independent risk factors for severe postoperative complications.  
Conclusion: Our results suggest that sarcopenia determined by using TPI, which can be easily obtained by examining the preoperative CT imaging, is an independent risk factor of severe postoperative complications. Determining the degree of sarcopenia can affect patient selection, predictability of possible serious complications, elective operation preparation process with a combination of nutrition and exercise therapy in a particular patient group and decisions regarding adjuvant or neoadjuvant therapy.
share this Article by

References

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62(1): 10-29.
2. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP et al. Validation of the 6th. edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007; 110(4): 738-44.
3. Winter JM, Brennan MF, Tang LH, D’Angelica MI, DeMatteo RP, Fong Y et al. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Annals of surgical oncology, 2012; 19(1), 169-175.
4. Sun RC, Button AM, Smith BJ, Leblond RF, Howe JR, Mezhir JJ A comprehensive assessment of transfusion in elective pancreatectomy: risk factors and complications. Journal of Gastrointestinal Surgery, 2013; 17(4), 627-635.
5. Van der Gaag NA, Harmsen K, Eshuis WJ, Busch ORC, Van Gulik TM, Gouma DJ. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death. European Journal of Surgical Oncology, 2014; 40(5), 551-558.
6. Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P et al. Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. Journal of Clinical Oncology, 2014; 32(6), 504-512.
7. Vollmer CM, Sanchez N, Gondek S, McAuliffe J, Kent TS, Christein JD et al. Pancreatic Surgery Mortality Study Group. A root-cause analysis of mortality following major pancreatectomy. Journal of gastrointestinal surgery, 2012; 16(1), 89-103.
8. Kneuertz PJ, Pitt HA, Bilimoria KY, Smiley JP, Cohen ME, Ko CY et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. Journal of Gastrointestinal Surgery, 2012; 16(9), 1727-1735.
9. Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. Journal of gastrointestinal surgery, 2012; 16(8), 1478-1486.

10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23.

11. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB et al. Alternative definitions of sarcopenia, lower extremity performance and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007; 55(5):769-74.

12. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006; 61(10):1059-64.

13. Kim TN, Choi KM. Sarcopenia. Definition, epidemiology, and pathophysiology. J Bone Metab. 2013; 21–10.

14. Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewé KW, Hoofwijk AG et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Annals of surgery, 2015; 261(2), 345-352.

15. Ongaro E, Buoro V, Cinausero M, Caccialanza R, Turri A, Fanotto V et al. Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer. 2017; 20(4): 563-572.

16. Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC geriatrics, 2017; 17(1), 188.

17. Japan Pancreas Society (2009) General rules for the study of pancreatic cancer, 6th. edn. Kanehara, Tokyo.
18. Dindo D, Demartines N, Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004; 240:205–213.
19. Dusch N, Lietzmann A, Barthels F, Niedergethmann M, Rückert F, Wilhelm TJ. International study group of pancreatic surgery definitions for postpancreatectomy complications: applicability at a high-volume center. Scandinavian Journal of Surgery, 2017; 106(3), 216-223.
20. Uzunoglu FG, Reeh M, Vettorazzi E, Ruschke T, Hannah P, Nentwich MF et al. Preoperative pancreatic resection (PREPARE) score: a prospective multicenter-based morbidity risk score. Ann Surg. 2014; 260:857–63.

21. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006; 10:1199 – 210.

22. Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer, 2016; 19(3), 986-993.

23. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Annals of surgical oncology, 2015; 22(8), 2663-2668.

24. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. The lancet oncology, 2011; 12(5), 489-495.
25. Grimm A, Meyer H, Nickel MD, Nittka M, Raithel E, Chaudry O et al. Repeatability of Dixon magnetic resonance imaging and magnetic resonance spectroscopy for quantitative muscle fat assessments in the thigh. Journal of cachexia, sarcopenia and muscle, 2018; 9(6), 1093-1100.
Published
2020-04-13
How to Cite
MERCAN, ümit; ERŞEN, ogün; ÜNAL, Ali Ekrem. The Effect of Sarcopenia on Postoperative Complications after Curative Pancreatectomy for Adenocarcinoma. Journal of Contemporary Medical Sciences, [S.l.], v. 6, n. 2, apr. 2020. ISSN 2413-0516. Available at: <http://www.jocms.org/index.php/jcms/article/view/738>. Date accessed: 12 aug. 2020. doi: https://doi.org/10.22317/jcms.v6i2.738.